Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NYSEConsumer DiscretionaryAuto - ManufacturersSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for XPEV yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successful launch and adoption of GX SUV and AI self-driving tech | The new GX SUV and AI self-driving tech investments could boost sales and innovation. | Improving | Product launches fail to gain market traction or AI investments do not advance | Sep deliveries 41,256 (up from Aug 39,107) vs sustained intake target XPeng delivered 41,256 vehicles in September, up from 39,107 in August. VW partnership faces execution challenges. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 16, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a growth-sensitive, elevated-risk investment rather than a clearly established durable compounder or turnaround. The current thesis state is unclear because there is not enough recent financial-performance history to assess it.
The evidence gives no valuation level or market expectations, so whether XPEV looks cheap, fair, or expensive versus peers cannot be assessed. The available pricing evidence shows low fragility, but it does not establish what business results are already assumed.
Near term, the stated miss risk is low, though the company has had a deep miss in its recent history. The evidence does not provide enough recent results or management-execution detail to describe a multi-year fundamental trajectory.
Near-term sector signals matter: continued earnings strength and higher guidance from bellwethers such as TSLA, GM, and F could support the sector backdrop, while misses or lower guidance could weaken it. The multi-year view also hinges on economic growth, since a material slowdown from the stated 2.1% level, especially below 2%, would pose a greater risk to growth-sensitive consumer businesses.
Over the next 1 to 3 years, the business case remains difficult to assess because recent financial evidence is limited, while sector and economic conditions are important swing factors. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
EPS turns positive by FY27 |
| A primary condition in XPeng Inc's published investment case. The stated target is EPS >= $3.9. |
| Broken |
| EPS remains negative beyond 2026 or fails to reach $3.9 in 2027 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth to exceed $117B by FY27 | A primary condition in XPeng Inc's published investment case. The stated target is >= $117B total revenue. | Broken | revenue falls below $92B in 2026 or fails to grow toward $117B in 2027 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.19 → $-0.36 · observed estimates
$119.79B → $112.50B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.19 | $119,792,396,469 | 7 / 21 |
| 2026-07-25 | $1.19 | $119,792,396,469 | 7 / 21 |
| 2026-07-26 | $1.19 | $119,792,396,469 | 7 / 21 |
| 2026-07-27 | $1.19 | $119,906,105,436 | 7 / 21 |
| 2026-07-28 | $1.19 | $119,906,105,436 | 7 / 21 |
| 2026-07-29 | $1.19 | $119,906,105,436 | 7 / 21 |
| 2026-07-30 | $1.19 | $119,906,105,436 | 7 / 21 |
| 2026-07-31 | $1.18 | $120,027,652,186 | 7 / 20 |
| 2026-08-01 | $1.18 | $120,027,652,186 | 7 / 20 |
| 2026-08-02 | $1.18 | $120,027,652,186 | 7 / 20 |
| 2026-08-03 | $1.18 | $120,214,560,514 | 7 / 20 |
| 2026-08-04 | $3.05 | $117,020,010,080 | 3 / 29 |
| 2026-08-05 | $1.18 | $120,214,560,514 | 7 / 20 |
| 2026-08-06 | $1.18 | $120,214,560,514 | 7 / 20 |
| 2026-08-08 | $1.18 | $120,214,560,514 | 7 / 20 |
| 2026-08-09 | $1.18 | $120,214,560,514 | 7 / 20 |
| 2026-08-10 | $2.58 | $116,538,498,310 | 3 / 29 |
| 2026-08-12 | $2.58 | $116,538,498,310 | 3 / 29 |
| 2026-08-13 | $2.58 | $116,538,498,310 | 3 / 29 |
| 2026-08-14 | $1.18 | $120,214,560,514 | 7 / 20 |
| 2026-08-15 | $1.18 | $120,214,560,514 | 7 / 20 |
| 2026-08-16 | $1.18 | $120,214,560,514 | 7 / 20 |
| 2026-08-17 | $1.18 | $120,214,560,514 | 7 / 20 |
| 2026-08-18 | $1.18 | $120,214,560,514 | 7 / 20 |
| 2026-08-19 | $1.18 | $120,214,560,514 | 7 / 20 |
| 2026-08-20 | $1.14 | $119,916,685,840 | 7 / 20 |
| 2026-08-21 | $1.15 | $120,175,720,128 | 7 / 20 |
| 2026-08-22 | $1.15 | $120,240,478,701 | 7 / 20 |
| 2026-08-23 | $1.15 | $120,240,478,701 | 7 / 20 |
| 2026-08-24 | $1.15 | $120,321,426,916 | 7 / 20 |
| 2026-08-25 | $0.74 | $118,407,705,568 | 7 / 21 |
| 2026-08-26 | $0.47 | $117,452,037,234 | 7 / 21 |
| 2026-08-27 | $0.47 | $117,452,037,234 | 7 / 21 |
| 2026-08-28 | $0.47 | $117,452,037,234 | 7 / 21 |
| 2026-08-29 | $0.26 | $115,755,213,940 | 7 / 22 |
| 2026-08-30 | $0.26 | $115,755,213,940 | 7 / 22 |
| 2026-08-31 | $0.22 | $115,425,090,796 | 7 / 22 |
| 2026-09-01 | $0.15 | $114,696,534,890 | 7 / 22 |
| 2026-09-02 | $-0.00 | $114,337,171,880 | 7 / 22 |
| 2026-09-03 | $-0.00 | $114,204,583,086 | 7 / 22 |
| 2026-09-04 | $-0.00 | $114,212,387,519 | 7 / 22 |
| 2026-09-05 | $-0.00 | $114,212,387,519 | 7 / 22 |
| 2026-09-06 | $-0.00 | $114,212,387,519 | 7 / 22 |
| 2026-09-07 | $-0.00 | $114,212,387,519 | 7 / 22 |
| 2026-09-08 | $-0.00 | $114,358,340,933 | 7 / 22 |
| 2026-09-09 | $0.03 | $114,381,386,209 | 7 / 22 |
| 2026-09-10 | $-0.03 | $115,114,911,411 | 7 / 22 |
| 2026-09-11 | $-0.03 | $115,215,380,955 | 7 / 22 |
| 2026-09-12 | $-0.03 | $115,215,380,955 | 7 / 22 |
| 2026-09-13 | $-0.12 | $114,620,362,534 | 7 / 22 |
| 2026-09-14 | $-0.12 | $114,620,376,349 | 7 / 22 |
| 2026-09-15 | $-0.12 | $114,528,114,174 | 7 / 22 |
| 2026-09-16 | $-0.14 | $114,187,657,229 | 7 / 22 |
| 2026-09-17 | $-0.14 | $114,141,657,099 | 7 / 22 |
| 2026-09-18 | $-0.14 | $114,141,657,099 | 7 / 22 |
| 2026-09-19 | $-0.14 | $114,141,657,099 | 7 / 22 |
| 2026-09-20 | $-0.13 | $114,094,897,158 | 7 / 22 |
| 2026-09-21 | $-0.12 | $112,540,081,461 | 7 / 22 |
| 2026-09-22 | $-0.12 | $112,689,270,865 | 7 / 22 |
| 2026-09-23 | $-0.12 | $112,823,432,778 | 7 / 22 |
| 2026-09-24 | $-0.12 | $112,823,432,778 | 7 / 22 |
| 2026-09-25 | $-0.11 | $112,797,783,570 | 7 / 22 |
| 2026-09-26 | $-0.11 | $112,889,041,407 | 7 / 22 |
| 2026-09-27 | $-0.11 | $112,889,041,407 | 7 / 22 |
| 2026-09-28 | $-0.11 | $113,004,860,952 | 7 / 22 |
| 2026-09-29 | $-0.11 | $112,807,002,389 | 7 / 22 |
| 2026-09-30 | $-0.11 | $112,868,506,351 | 7 / 22 |
| 2026-10-01 | $-0.20 | $112,201,548,324 | 7 / 21 |
| 2026-10-02 | $-0.23 | $111,881,922,203 | 7 / 21 |
| 2026-10-03 | $-0.23 | $111,899,612,627 | 7 / 21 |
| 2026-10-04 | $-0.23 | $111,899,612,627 | 7 / 21 |
| 2026-10-05 | $-0.23 | $111,899,167,585 | 7 / 21 |
| 2026-10-06 | $-0.23 | $111,899,167,585 | 7 / 21 |
| 2026-10-07 | $-0.23 | $112,011,870,701 | 7 / 21 |
| 2026-10-08 | $-0.23 | $111,989,330,078 | 7 / 21 |
| 2026-10-09 | $-0.23 | $111,981,816,537 | 7 / 21 |
| 2026-10-10 | $-0.23 | $111,981,816,537 | 7 / 21 |
| 2026-10-11 | $-0.28 | $111,981,816,537 | 7 / 21 |
| 2026-10-12 | $-0.28 | $112,145,859,311 | 7 / 20 |
| 2026-10-13 | $-0.28 | $112,227,093,735 | 7 / 20 |
| 2026-10-14 | $-0.28 | $112,228,907,181 | 7 / 20 |
| 2026-10-15 | $-0.28 | $112,228,975,137 | 7 / 20 |
| 2026-10-16 | $-0.28 | $112,235,045,000 | 7 / 20 |
| 2026-10-17 | $-0.28 | $112,235,045,000 | 7 / 20 |
| 2026-10-18 | $-0.28 | $112,265,098,567 | 7 / 20 |
| 2026-10-19 | $-0.28 | $112,265,098,567 | 7 / 20 |
| 2026-10-20 | $-0.28 | $112,265,098,567 | 6 / 20 |
| 2026-10-21 | $-0.28 | $112,362,772,659 | 6 / 20 |
| 2026-10-22 | $-0.28 | $112,460,446,751 | 6 / 20 |
| 2026-10-23 | $-0.38 | $112,279,667,039 | 6 / 20 |
| 2026-10-24 | $-0.38 | $112,068,143,272 | 6 / 20 |
| 2026-10-25 | $-0.38 | $112,068,143,272 | 7 / 20 |
| 2026-10-26 | $-0.38 | $112,068,143,272 | 7 / 20 |
| 2026-10-27 | $-0.38 | $112,068,143,272 | 7 / 20 |
| 2026-10-28 | $-0.36 | $112,146,945,094 | 7 / 20 |
| 2026-10-29 | $-0.36 | $112,274,206,163 | 7 / 20 |
| 2026-10-30 | $-0.36 | $112,221,804,546 | 7 / 20 |
| 2026-10-31 | $-0.36 | $112,356,551,559 | 7 / 20 |
| 2026-11-01 | $-0.36 | $112,356,551,559 | 7 / 20 |
| 2026-11-02 | $-0.36 | $112,356,551,559 | 7 / 20 |
| 2026-11-03 | $-0.36 | $112,459,657,259 | 7 / 20 |
| 2026-11-04 | $-0.36 | $112,504,566,273 | 7 / 20 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 19 Buy / Strong Buy · 4 Hold · 2 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.